Fondazione Policlinico Universitario Agostino Gemelli Irccs
Clinical trials sponsored by Fondazione Policlinico Universitario Agostino Gemelli Irccs, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New surgical tool may ease recovery for jaw bone disease patients Results expected Sep 2026 (estimated)
- Fat cells injected into esophagus could tame reflux without surgery Results expected Sep 2026 (estimated)
- Scientists map immune cells in pituitary tumors to unlock new treatments Results expected Sep 2026 (estimated)
- Lab-Grown lung tumors could reveal why some drugs work and others fail Results expected Sep 2026 (estimated)
- Could a mouth condition signal heart trouble? new study investigates Results expected Sep 2026 (estimated)
-
Personalized ventilation for ARDS: early trial halted, results uncertain
Disease control Stopped earlyThis study tested whether setting a ventilator based on each patient's lung volume could improve outcomes for people with moderate-to-severe acute respiratory distress syndrome (ARDS). The approach used a bedside measurement to tailor the pressure applied during breathing. Howeve…
Phase 3 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Treadmill training may slow Parkinson's by fighting inflammation
Knowledge-focused Stopped earlyThis study looked at whether intensive treadmill exercise can improve motor symptoms and reduce inflammation in people with early-stage Parkinson's disease. Researchers measured changes in movement scores and blood markers of nerve damage and inflammation in 30 patients who eithe…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:10 UTC